PET/CT imaging in different types of lung cancer: An overview

被引：121

作者：

Ambrosini, Valentina ^{[2
]}

Nicolini, Silvia ^{[2
]}

Caroli, Paola ^{[2
]}

Nanni, Cristina ^{[2
]}

Massaro, Arianna

Marzola, Maria Cristina

Rubello, Domenico ^{[1
]}

Fanti, Stefano ^{[2
]}

机构：

[1] Santa Maria della Misericordia Hosp, Dept Radiol, PET CT Ctr, I-45100 Rovigo, Italy

[2] St Orsola Malpighi Hosp, Dept Nucl Med, Bologna, Italy

来源：

EUROPEAN JOURNAL OF RADIOLOGY | 2012年 / 81卷 / 05期

关键词：

Lung cancer; Various types; PET/CT; 18F-FDG; 18F-DOPA; 68Ga-DOTA-peptides; Indications; Drawbacks; POSITRON-EMISSION-TOMOGRAPHY; SOLITARY PULMONARY NODULES; STANDARDIZED UPTAKE VALUE; GUIDELINES 2ND EDITION; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; FORTHCOMING 7TH EDITION; FDG-PET; NEUROENDOCRINE TUMORS; F-18-FDG PET; BRONCHIOLOALVEOLAR CARCINOMA;

D O I：

10.1016/j.ejrad.2011.03.020

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Lung cancer (LC) still represents one of the most common tumours in both women and men. PET/CT is a whole-body non-invasive imaging procedure that has been increasingly used for the assessment of LC patients. In particular, PET/CT added value to CT is mainly related to a more accurate staging of nodal and metastatic sites and to the evaluation of the response to therapy. Although the most common PET tracer for LC evaluation is 18F-FDG, new tracers have been proposed for the evaluation of lung neuroendocrine tumours (68Ga-DOTA-peptides, 18F-DOPA) and for the assessment of central nervous system metastasis (11C-methionine). This review focuses on the main clinical applications and accuracy of PET/CT for the detection of non-small cells lung cancer (NSCLC), broncho-alveolar carcinoma (BAC), small cells lung cancer (SCLC), lung neuroendocrine tumours (NET) and solitary pulmonary nodules (SPN). (C) 2011 Elsevier Ireland Ltd. All rights reserved.

引用

页码：988 / 1001

页数：14

共 50 条

[31] Imaging features of 18F-FDG PET/CT in different types of systemic vasculitis
Chen, Zhuo
Zhao, Yunyun
Wang, Qian
Li, Yuan
Li, Hebei
Zhou, Yunshan
CLINICAL RHEUMATOLOGY, 2022, 41 (05) : 1499 - 1509
[32] PET/CT imaging in prostate cancer
Tara Barwick
Cancer Imaging, 15 (Suppl 1)
[33] INTEGRATED PET/CT AND CANCER IMAGING
De Wever, W.
Coolen, J.
Verschakelen, J. A.
JBR-BTR, 2009, 92 (01): : 13 - 19
[34] PET/CT Imaging of Thyroid Cancer
Mosci, Camila
Iagaru, Andrei
CLINICAL NUCLEAR MEDICINE, 2011, 36 (12) : E180 - E185
[35] PET-CT Cancer Imaging
Furlow, Bryant
RADIOLOGIC TECHNOLOGY, 2018, 90 (02) : 149CT - 170CT
[36] Imaging in colorectal cancer: PET/CT
Votrubova, J.
PROCEEDINGS OF THE SECOND ANNUAL MEETING OF THE EUROPEAN SOCIETY OF COLOPROCTOLOGY, 2007, : 63 - 65
[37] Diagnostic Value of Spectral CT Parameters in Differentiating Different Types of Lung Cancer
Chen, Mai-Lin
Li, Xiao-Ting
Wei, Yi-Yuan
Qi, Li-Ping
Sun, Ying-Shi
JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS, 2020, 10 (08) : 1804 - 1808
[38] Application of PET and PET/CT imaging for cancer screening
Chen, YK
Ding, HJ
Su, CT
Shen, YY
Chen, LK
Liao, AC
Hung, TZ
Hu, FL
Kao, CH
ANTICANCER RESEARCH, 2004, 24 (06) : 4103 - 4108
[39] FDG PET, PET/CT, and breast cancer imaging
Rosen, Eric L.
Eubank, William B.
Mankoff, David A.
RADIOGRAPHICS, 2007, 27 : S215 - S229
[40] Comparison of FDG PET/CT and PET/MR Imaging for Primary Staging of Newly Diagnosed Lung Cancer
Erbil, E.
Aydos, U.
Akdemir, U.
Karabacak, N.
Atay, L.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S484 - S485

← 1 2 3 4 5 →